enrofloxacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birtles, RJ; Dixon, CE; Hetzel, U; Just, AE; Kipar, A | 1 |
| Hughes, KL; Studdert, VP | 1 |
2 other study(ies) available for enrofloxacin and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Mycobacterium malmoense as an extrapulmonary pathogen of cats.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cat Diseases; Cats; Enrofloxacin; Female; Fluoroquinolones; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Patient Compliance; Rifampin; Treatment Outcome | 2012 |
Treatment of opportunistic mycobacterial infections with enrofloxacin in cats.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Enrofloxacin; Female; Fluoroquinolones; Male; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Quinolones; Skin Diseases, Infectious; Wound Infection | 1992 |